Assyro AI

Orange Book product · Brand (NDA)

TOLSURA

ITRACONAZOLE

Brand (NDA)NDA 208901RX MAYNE PHARMA

At a glance

Dec 11, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

5

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 11, 2018

    7 yr 8 mo ago

  2. Today

  3. Patent 10463740 expires

    Listed drug product patent expiration.

    Jun 21, 2033

    in 7 yr 1 mo

  4. Patent 10806792 expires

    Listed drug product patent expiration.

    Jun 21, 2033

    in 7 yr 1 mo

  5. Patent 8921374 expires

    Listed drug product patent expiration.

    Jun 21, 2033

    in 7 yr 1 mo

  6. Patent 9272046 expires

    Listed drug product patent expiration.

    Jun 21, 2033

    in 7 yr 1 mo

  7. Patent 9713642 expires

    Listed method-of-use patent (U-2453) expiration.

    Jun 21, 2033

    in 7 yr 1 mo

Pharmaceutical detail

Active ingredient

ITRACONAZOLE

Strength

65MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 208901

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10463740Jun 21, 2033in 7 yr 1 mo
ProductU-2453
10806792Jun 21, 2033in 7 yr 1 mo
Product
8921374Jun 21, 2033in 7 yr 1 mo
Product
9272046Jun 21, 2033in 7 yr 1 mo
Product
9713642Jun 21, 2033in 7 yr 1 mo
U-2453
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.